Metabolomics
Description
The real-world efficacy, predictive biomarkers, and resistance mechanisms of Tumor Treating Fields (TTFields)-based triple therapy (combined with radiotherapy and temozolomide) in high-grade glioma (HGG) remain poorly defined. This study aimed to evaluate the survival benefit of triple therapy and identify genomic determinants of treatment response in the real-word cohort study.
Files
Steps to reproduce
Raw Data Processing: The raw LC-MS metabolomics data (acquired in negative ion mode) were imported into Agilent MassHunter Profinder software for data deconvolution, peak picking, peak alignment, and integration of both identified and unidentified compounds. Data Filtering: To ensure data quality and reliability, the extracted feature matrix was subjected to a strict frequency filter. Specifically, entities (metabolite features) were retained only if they appeared in at least 100.0% of the biological replicates in any 1 out of the 2 experimental conditions (Sensitive vs. Resistant groups). Flag Evaluation: Features were evaluated based on flag values [Present, Marginal, Absent] across the grouped samples (non-averaged) to eliminate high-noise or irreproducible background signals. Final Output: The uploaded dataset represents the final processed intensity matrix containing the filtered entities, which was subsequently used for downstream differential and multivariate statistical analyses.
Institutions
- Nanfang HospitalGuangdong, Guangzhou